case_images: PMC11188369_01
case_images: Changes in platelet count in relation to treatment.
case_images: fimmu-15-1382964-g001.jpg
case_images: PMC11188369_01_fimmu-15-1382964-g001.jpg
case_images: f1
case_images: Figure 1 ). Furthermore, the patient developed acute thrombocytopenia on the first day after the sixth cycle of bevacizumab infusion. Complete blood count showed an isolated decrease in platelet count from 120 x 103/mul (as measured before chemotherapy infusion) to 52 x 103/mul ( Figure 1 ). Despite this treatment, platelet count continued to drop to 31 x 103/mul on day 10 after the administration of bevacizumab ( Figure 1 ). Platelet count gradually increased up to 122 x 103/mul 6 days later ( Figure 1 ).